Cargando…
Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study
Artemisinin (also known as Qinghaosu), an active component of the Qinghao extract, is widely used as antimalarial drug. Previous studies reveal that artemisinin and its derivatives also have effective anti-inflammatory and immunomodulatory properties, but the direct molecular target remains unknown....
Autores principales: | Qiao, Sennan, Zhang, Hansi, Sun, Fei, Jiang, Zhenyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469597/ https://www.ncbi.nlm.nih.gov/pubmed/34577169 http://dx.doi.org/10.3390/molecules26185698 |
Ejemplares similares
-
Molecular basis of rutin inhibition of protein disulfide isomerase (PDI) by combined in silico and experimental methods
por: Wang, Xu, et al.
Publicado: (2018) -
Artemisinin Derivatives Target Topoisomerase 1 and Cause DNA Damage in Silico and in Vitro
por: Kadioglu, Onat, et al.
Publicado: (2017) -
In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative
por: Tsamesidis, Ioannis, et al.
Publicado: (2022) -
Inhibition of P-glycoprotein by two artemisinin derivatives
por: Steglich, Babette, et al.
Publicado: (2012) -
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
por: Dolivo, David, et al.
Publicado: (2021)